Adimab
Gilbert Choi is a Corporate Attorney at Adimab since August 2022, with prior experience as a Technology Transactions Associate at Morrison & Foerster LLP from February 2021 to August 2022, following a role as a Summer Associate at the same firm in summer 2019, focusing on technology transactions and IP litigation. Earlier, Gilbert gained experience in patent litigation as a Summer Associate at Weil, Gotshal & Manges LLP in summer 2018. Academic credentials include a Doctor of Law (JD) from the University of California, Berkeley - School of Law, a Ph.D. in Organic Chemistry from Princeton University, and a B.A. in Chemistry from Columbia University. Gilbert also served as a Graduate Research Assistant and Graduate Teaching Assistant at Princeton University and as an Undergraduate Research Assistant at Columbia University.
This person is not in any teams
This person is not in any offices
Adimab
1 followers
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.